Harvest One Cannabis Inc. (TSXV: HVT) (OTCQB: HRVOF) ("Harvest One" or the "Company"), a CPG leader uniquely positioned in both the OTC and cannabis space with a focus on non-infused and cannabis-infused health and wellness products, announced today that its subsidiares DreamWater ^TM and LivRelief ^TM have signed a sales and distribution agreement (the "Agreement") with leading distributor Pharmtick Limited ("Pharmtick"), based in Nigeria, Africa, to further expand their international distribution networks. Under the Agreement, Pharmtick will sell and distribute DreamWater ^TM and LivRelief ^TM products throughout Africa, for a term of three years.

"Aligning our core brands with one of Africa's leading healthcare and wellness distributors is an important step in the continuing advancement of Harvest One's international distribution strategy," said Gord Davey President and Chief Executive Officer of Harvest One. "Global expansion is a key priority for Harvest One. Our e-commerce sales in North America have grown significantly and expanded the reach of our brands. Gaining access to additional international markets, such as Africa, is an important milestone for Harvest One. Pharmtick has access to online distribution throughout several prominent countries in Africa and we strongly believe that Pharmtick is the right partner to lead our marketing and product awareness efforts in a new continent."

Pharmtick is a leading African consumer goods distributor representing prominent brands such as Pfizer, Bayer, GlaxoSmithKline, Novartis, TEVA, Actavis, Accord and Vitabiotics. Pharmtick has a growing number of leading over-the-counter products including cold, flu, allergy, heartburn and immune booster products.

For more information on Pharmtick please visit their website at: www.pharmtick.com

About Harvest One

Harvest One is a global cannabis-infused and non-infused CPG leader that develops and distributes premium health, wellness and selfcare products with a market focus on solutions for sleeplessness and pain, resulting in the reduction of fatigue and anxiety. Harvest One is a uniquely positioned company in the cannabis space which is commercializing both cannabis-infused and non-infused products. Harvest One has established an impressive track record in product innovation, branding, marketing and distribution through its portfolio of CPG brands. Harvest One owns and operates two subsidiaries; DreamWater^TM and LivRelief^TM. For more information, please visit  www.harvestone.com.

Cautionary Note Regarding Forward-Looking Statements

This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates, and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements include, among other things, statements with respect to the magnitude of expansion of the Company's products into Africa, the continued success of the Company's international distribution strategy, global expansion being a key priority for the Company, growth of e-commerce sales of the Company in the future, additional access to international markets, the success of the transactions contemplated under the Agreement, future increased revenues and sustainable success of the Company, and future expansion plans, initiatives and strategies of the Company.

These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: implications of the COVID-19 pandemic on the Company's operations; fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the cannabis markets where the Company operates; changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political and social uncertainties; inability to obtain adequate insurance to cover risks and hazards; employee relations and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution, and sale of cannabis and cannabis-related products in the markets where the Company operates. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

Additional information regarding this and other risks and uncertainties relating to the Company's business are contained under the heading "Risk Factors" in the Company's AIF, and under the heading "Risks and Uncertainties" in the Company's Management's Discussion and Analysis dated March 1, 2022, for the three months ended December 31, 2021, filed under the Company's profile on SEDAR at www.sedar.com.

Neither TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accept responsibility for the adequacy or accuracy of this release.

Investor Relations:
Jack Tasse
Chief Financial Officer
This email address is being protected from spambots. You need JavaScript enabled to view it.
1-877-915-7934

47893876.5